A cholesterol-lowering diet during pregnancy may do more than just modify maternal lipid levels; it may significantly reduce the rate of preterm birth among low-risk women, according to researchers from Norway.
A cholesterol-lowering diet during pregnancy may do more than just modify maternal lipid levels; it may significantly reduce the rate of preterm birth among low-risk women, according to researchers from Norway.
The researchers found that while a Mediterranean-style diet rich in fish, low-fat meats, dairy products, oils, whole grains, fruits, vegetables, and legumes did not alter lipid levels in cord blood or in neonates born to mothers in the intervention group, when compared to controls, it did lower maternal total and low-density lipoprotein cholesterol levels (P<0.01) and lowered the rate of preterm birth from 7.4% among controls to 0.7% in the intervention group.
While the basis of the relationship is uncertain, one proposed theory is that diets low in saturated fat and cholesterol and enriched with polyunsaturated fatty acids may influence cytokine levels, which have been proposed as markers of preterm delivery. Another theory is that polyunsaturated fatty acids have an antiarrhythmic effect on the myometrium. And still another is that micronutrients such as vitamins C and E may prolong gestation.
Cesarean delivery reduces mortality risk in preterm breech births
December 2nd 2024In a recent study, infants born very preterm or extremely preterm had reduced odds of mortality when cesarean delivery was chosen as the mode of delivery, without a notable increase in any morbidity risk.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More